期刊文献+

高分辨率熔解曲线分析法检测胶质瘤中异柠檬酸脱氢酶1基因突变 被引量:1

Application of high resolution melting analysis in detecting IDH1 mutation in glionm patients
原文传递
导出
摘要 目的采用高分辨率溶解曲线分析法检测胶质瘤中异柠檬酸脱氢酶1(IDH1)基因突变,探讨其应用于临床检测的可行性。方法首先采用高分辨率溶解曲线分析法检测9例胶质瘤患者中IDH1基因的突变情况,并以直接测序法对结果进行验证。结果通过高分辨率熔解曲线分析法,确认9例胶质瘤患者中有6例发生了IDH1突变,其中5例为R132H(CGT〉CAT),1例为R132C(CGT〉TGT),其余检测均为野生型。经直接测序对以上9例标本进行验证,证实所有患者的突变情况与高分辨率熔解曲线分析法的结果一致。结论应用高分辨率熔解曲线分析法检测临床样本IDH1突变与直接测序法比较具有操作简便、快速、结果准确的优点,适合在临床开展。 Objective To evaluate the feasibility of detecting the mutation of IDH1 in glioma patients by high resolution melting(HRM) curve analysis. Methods The gene mutation of IDH1 was detected by HRM method in 9 surgical resection paraffin specimens of glioma, and the result was verified by gene sequencing. Results 6 cases of R132H( CGT 〉 CAT) mutation and 1 case of R132C ( CGT 〉 TGT) mutation were found by HRM method. The resluts of direct gene sequencing were consistent with HRM method. Conclusion The HRM method in detecting IDH1 mutation is more efficient and convenient than direct sequencing. Moreover, it has advantages of low-cost and suitable for clinical test.
出处 《中国基层医药》 CAS 2013年第22期3379-3380,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 胶质瘤 突变 IDH1基因 高分辨率熔解曲线分析 Glioma Mutation IDH1 gene High resolution mehing curve analysis
  • 相关文献

参考文献13

  • 1Parsons DW,Jones S, Zhang X, et al. An integrated genomic analy- sis of human glioblastoma multiforme. Science, 2008,32 ( 5897 ) : 1807-1812.
  • 2Nobusawa S, Yokoo H. IDH1/2 mutations in gliomas. Brain Nerve, 2011,63 (12) : 1378-1386.
  • 3Rossetto M, Ciccarino P, Boisselier B, et al. Metabolism of glioma and IDH1/IDH2 mutations. Rev Neurol, 2011,167 ( 10 ) : 699- 703.
  • 4Ahmadi R, Stockhammer F, Becker N, et al. No prognostic value of IDH1 mutations in a series of 100 WHO grade lI astrocytomas. J Neuroonco1,2012,109 ( 1 ) : 15-22.
  • 5Juratli TA, Kirsch M, Robel K, et al. IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neuroon- col ,2012,108 ( 3 ) :403-410.
  • 6Gorovets D, Kannan K, Shen R, et al. IDH mutation and neurogli- al developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma. Clin Cancer Res,2012,18 (9) :2490-2501.
  • 7Thota B, Shukla SK, Srividya MR, et al. IDH1 mutations in dif- fusely infiltrating astrocytomas : grade specificity, association with protein expression, and clinical relevance. Am J Clin Pathol, 2012,138(2) :177-184.
  • 8Leibetseder A,Ackerl M, Flechl B, et al. Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma : a study of the Society of Austrian Neurooncology (SANO). Neuro Onco1,2013,15 ( 1 ) : 112-121.
  • 9Houillier C, Wang X, Kaloshi G, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology ,2010,75 ( 17 ) : 1560-1566.
  • 10Hartmann C, Hentschel B,Wick W, et al. Patients with IDH1 wild type anaplastic astroeytom as exhibit worse prognosis than IDHI- mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age : implications for classi- fication of gliomas. Acta Neuropatho1,2010,120 ( 6 ) :707-718.

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部